|
1
|
Sharkas G, Arqoub K, Khader Y, Nimri O,
Shroukh W, Jadallah H and Saheb T: Trends in the incidence of
cervical cancer in Jordan, 2000–2013. J Oncol. 2017:68273842017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aho I, Kivelä P, Haukka J, Sutinen J and
Heikinheimo O: Declining prevalence of cytological squamous
intraepithelial lesions of the cervix among women living with
well-controlled HIV-most women living with HIV do not need annual
PAP smear screening. Acta Obstet Gynecol Scand. 96:1330–1337. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luttmer R, Berkhof J, Dijkstra MG, van
Kemenade FJ, Snijders PJ, Heideman DA and Meijer CJ: Comparing
triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection
and cytology in high-risk HPV DNA-positive women. J Clin Virol.
67:59–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim NR, Lin Z, Kim KR, Cho HY and Kim I:
Epstein-Barr virus and p16INK4A methylation in squamous cell
carcinoma and precancerous lesions of the cervix uteri. J Korean
Med Sci. 20:636–642. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carreras R, Alameda F, Mancebo G,
García-Moreno P, Mariñoso ML, Costa C, Fusté P, Baró T and Serrano
S: A study of Ki-67, c-erbB2 and cyclin D-1 expression in CIN-I,
CIN-III and squamous cell carcinoma of the cervix. Histol
Histopathol. 22:587–592. 2007.PubMed/NCBI
|
|
6
|
Iaconis L, Hyjek E, Ellenson LH and Pirog
EC: p16 and Ki-67 immunostaining in atypical immature squamous
metaplasia of the uterine cervix: correlation with human
papillomavirus detection. Arch Pathol Lab Med. 131:1343–1349.
2007.PubMed/NCBI
|
|
7
|
Wang X, Wang G, Zhang L, Cong J, Hou J and
Liu C: LncRNA PVT1 promotes the growth of HPV positive and negative
cervical squamous cell carcinoma by inhibiting TGF-β1. Cancer Cell
Int. 18:702018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bulk S, Berkhof J, Bulkmans NW, Zielinski
GD, Rozendaal L, van Kemenade FJ, Snijders PJ and Meijer CJ:
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18
for adenocarcinoma of the cervix compared to women with normal
cytology in The Netherlands. Br J Cancer. 94:171–175. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sano T, Masuda N, Oyama T and Nakajima T:
Overexpression of p16 and p14ARF is associated with human
papillomavirus infection in cervical squamous cell carcinoma and
dysplasia. Pathol Int. 52:375–383. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cioffi-Lavina M, Chapman-Fredricks J,
Gomez-Fernandez C, Ganjei-Azar P, Manoharan M and Jorda M: P16
expression in squamous cell carcinomas of cervix and bladder. Appl
Immunohistochem Mol Morphol. 18:344–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tozawa-Ono A, Yoshida A, Yokomachi N,
Handa R, Koizumi H, Kiguchi K, Ishizuka B and Suzuki N: Heat shock
protein 27 and p16 immunohistochemistry in cervical intraepithelial
neoplasia and squamous cell carcinoma. Hum Cell. 25:24–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheah PL, Looi LM, Mun KS, Abdoul Rahman N
and Teoh KH: Implications of continued upregulation of p16(INK4a)
through the evolution from high-grade squamous intraepithelial
lesion to invasive squamous carcinoma of the cervix. Malays J
Pathol. 33:83–87. 2011.PubMed/NCBI
|
|
13
|
Wang Z, Dong J, Eyzaguirre EJ, Tang WW,
Eltorky MA and Qiu S: Detection of human papilloma virus subtypes
16 and P16(ink4a) in invasive squamous cell carcinoma of the
fallopian tube and concomitant squamous cell carcinoma in situ of
the cervix. J Obstet Gynaecol Res. 35:385–389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu JQ, Zhou Q, Zheng YF and Bao Y:
Expression of vimentin and Ki-67 proteins in cervical squamous cell
carcinoma and their relationships with clinicopathological
features. Asian Pac J Cancer Prev. 16:4271–4275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gertych A, Joseph AO, Walts AE and Bose S:
Automated detection of dual p16/Ki67 nuclear immunoreactivity in
liquid-based Pap tests for improved cervical cancer risk
stratification. Ann Biomed Eng. 40:1192–1204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davidson B, Goldberg I, Lerner-Geva L,
Gotlieb WH, Ben-Baruch G, Novikov I and Kopolovic J: Expression of
topoisomerase II and Ki-67 in cervical carcinoma -
clinicopathological study using immunohistochemistry. APMIS.
108:209–215. 2000. View Article : Google Scholar : PubMed/NCBI
|
